The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to continue their research.The FDA provided recommendations to investigators ...

Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based ...

Teens with cancer who participated in family-centered advance care planning reported greater levels of pain, depression and ...

Micronutrient deficiencies commonly occur in individuals with type 2 diabetes, according to a systematic review and ...

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

According to published results, robotic-assisted medial patellofemoral ligament reconstruction yielded more accurate femoral ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...

The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel large-bore ...

Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially ...

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Using a handheld dynamometer to assess hip flexion and abduction strength during dialysis was reliable and safe, researchers ...